# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Emily Bodnar reiterates Genelux (NASDAQ:GNLX) with a Buy and maintains $32 price target.
Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8....
Benchmark analyst Bruce Jackson reiterates Genelux (NASDAQ:GNLX) with a Speculative Buy and maintains $25 price target.
Benchmark analyst Bruce Jackson maintains Genelux (NASDAQ:GNLX) with a Speculative Buy and lowers the price target from $30 ...